MX2010002754A - Composicion farmaceutica antidiabetica. - Google Patents

Composicion farmaceutica antidiabetica.

Info

Publication number
MX2010002754A
MX2010002754A MX2010002754A MX2010002754A MX2010002754A MX 2010002754 A MX2010002754 A MX 2010002754A MX 2010002754 A MX2010002754 A MX 2010002754A MX 2010002754 A MX2010002754 A MX 2010002754A MX 2010002754 A MX2010002754 A MX 2010002754A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
indole derivatives
antidiabetic
toxic
antidiabetic pharmaceutical
Prior art date
Application number
MX2010002754A
Other languages
English (en)
Spanish (es)
Inventor
Alexander Victorovich Demin
Vitaly Afanasievich Martianov
Alexander Mihaylovich Shuster
Original Assignee
Zakrytoe Aktsionernoe Obschest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zakrytoe Aktsionernoe Obschest filed Critical Zakrytoe Aktsionernoe Obschest
Publication of MX2010002754A publication Critical patent/MX2010002754A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2010002754A 2007-09-14 2008-05-22 Composicion farmaceutica antidiabetica. MX2010002754A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007134267/15A RU2361581C2 (ru) 2007-09-14 2007-09-14 Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
PCT/RU2008/000320 WO2009035368A1 (en) 2007-09-14 2008-05-22 Antidiabetic pharmaceutical composition

Publications (1)

Publication Number Publication Date
MX2010002754A true MX2010002754A (es) 2010-03-30

Family

ID=40452228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002754A MX2010002754A (es) 2007-09-14 2008-05-22 Composicion farmaceutica antidiabetica.

Country Status (11)

Country Link
US (1) US8247407B2 (https=)
EP (1) EP2204173B1 (https=)
JP (1) JP2010539160A (https=)
KR (1) KR20100086981A (https=)
CN (1) CN101801373B (https=)
AU (1) AU2008297608A1 (https=)
BR (1) BRPI0815200A2 (https=)
CA (1) CA2699403A1 (https=)
MX (1) MX2010002754A (https=)
RU (1) RU2361581C2 (https=)
WO (1) WO2009035368A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
RU2421219C1 (ru) * 2009-11-19 2011-06-20 Закрытое Акционерное Общество "Мастерклон" Ингибиторы протеинкиназы с

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3510491A (en) * 1967-02-02 1970-05-05 Sterling Drug Inc 4-(cyclicaminomethyl)-5-hydroxyindole-3-carboxylic acids and esters thereof
US4226829A (en) * 1978-10-04 1980-10-07 Andrew Mike Renewable vaporizer for air treatment and the like
US4889286A (en) * 1988-09-19 1989-12-26 Donald Spector Controllable air freshener unit
FR2674522B1 (fr) * 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
DE19753956A1 (de) * 1997-12-05 1999-06-17 Draeger Sicherheitstech Gmbh Duftpatrone
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CN100457730C (zh) * 2002-08-29 2009-02-04 默克公司 具有抗糖尿病活性的吲哚化合物
AR041481A1 (es) 2002-10-07 2005-05-18 Hoffmann La Roche Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
CA2502269C (en) 2002-10-18 2009-12-22 Merck & Co., Inc. Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2005102320A1 (fr) 2004-04-21 2005-11-03 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicament pour traiter des infections virales
US20060233538A1 (en) * 2005-04-14 2006-10-19 Tollens Fernando R Energized systems and devices for delivering volatile materials
WO2007075102A1 (en) 2005-12-28 2007-07-05 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicinal agent for treating viral infections
US20070176015A1 (en) * 2006-01-30 2007-08-02 The Procter & Gamble Company System for delivering volatile materials
WO2007136302A2 (en) 2006-05-23 2007-11-29 Alla Chem, Llc Active substances, pharmaceutical composition and a method for the production and use thereof
US8329689B2 (en) 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
RU2344817C1 (ru) 2007-06-19 2009-01-27 Андрей Александрович Иващенко Замещенные эфиры 5-гидрокси-1н-индол-3-карбоновой кислоты, фармацевтическая композиция, способ их получения и применения
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний

Also Published As

Publication number Publication date
EP2204173A1 (en) 2010-07-07
CN101801373A (zh) 2010-08-11
AU2008297608A1 (en) 2009-03-19
BRPI0815200A2 (pt) 2015-03-31
RU2361581C2 (ru) 2009-07-20
EP2204173A4 (en) 2010-12-29
JP2010539160A (ja) 2010-12-16
US8247407B2 (en) 2012-08-21
CA2699403A1 (en) 2009-03-19
CN101801373B (zh) 2013-03-27
US20100168092A1 (en) 2010-07-01
EP2204173B1 (en) 2013-07-03
WO2009035368A1 (en) 2009-03-19
KR20100086981A (ko) 2010-08-02
RU2007134267A (ru) 2009-03-20

Similar Documents

Publication Publication Date Title
Hughes et al. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl) amino] ethyl] amino] acetyl]-2-cyano-(S)-pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV
MY149622A (en) Pyrazoles as 11-beta-hsd-1
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
TW200745052A (en) Thyroid hormone receptor agonists
GEP20115359B (en) Fused cyclic compounds
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
TW200606147A (en) Indolyl derivatives as liver-X-receptor modulators
ATE303178T1 (de) Acc-hemmer
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
TW200745037A (en) Organic compounds
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
WO2007062078A3 (en) Thrombopoietin activity modulating compounds and methods
ATE449604T1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
MX2009012285A (es) Inhibidores de diacilglicerol aciltransferasa.
NO20091734L (no) Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse
DE602007007473D1 (en) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
CL2007001886A1 (es) Compuestos derivados de ureas de piperidina o pirrolidina; procedimiento de preparación; composición farmacéutica; y su uso como moduladores de la actividad de la 11ß-hidroxiesteroide deshidrogenasa tipo 1 (11ßhsd1) para tratar la obesidad, diabetes, resistenacia a la insulina, síndrome de cushing e hipertensión, entre otros.
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
TW200745044A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
MX2010002754A (es) Composicion farmaceutica antidiabetica.
BRPI0417469B8 (pt) bifenil carboxamidas substituídas com n-aril piperidina, composição farmacêutica que os compreende e processo de preparação destes
DE602005024384D1 (de) Neue verbindungen, ihre herstellung und verwendung
AU2005238141A8 (en) Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof

Legal Events

Date Code Title Description
FG Grant or registration